Phase 2 NK-Cell Leukemia Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
Aggressive NK-cell LeukemiaLGLL - Large Granular Lymphocytic LeukemiaPrimary Cutaneous Gamma-Delta T-Cell Lymphoma+10 more
Dren Bio200 enrolled37 locationsNCT05475925
Recruiting
Phase 1Phase 2
Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia
Aggressive NK-cell Leukemia
Hiroshima University Hospital7 enrolled1 locationNCT05863234
Recruiting
Phase 2
Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia
NK-Cell LeukemiaExtranodal NK T Cell Lymphoma
The Affiliated Hospital of Xuzhou Medical University20 enrolled1 locationNCT05941156